Kalechstein, Ari D <br/><br/>
Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.  [electronic resource] 

 -  Pharmacology, biochemistry, and behavior  Sep 2011 
 - 423-7 p.  digital 
<br/><br/> Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1873-5177 
<br/><br/><label>Standard No.: </label>10.1016/j.pbb.2011.05.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Amphetamine-Related Disorders--drug therapy<br/>Attention--drug effects<br/>Cognition--drug effects<br/>Dose-Response Relationship, Drug<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Methamphetamine--adverse effects<br/>Middle Aged<br/>Neuroprotective Agents--administration & dosage<br/>Phenylcarbamates--administration & dosage<br/>Rivastigmine<br/>Time Factors<br/>Young Adult